We are live on ! Find out more
VA

Vident Advisory Portfolio holdings

AUM $11.7B
1-Year Est. Return 37.32%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+37.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.62B
AUM Growth
-$1.18B
Cap. Flow
-$1.18B
Cap. Flow %
-32.7%
Top 10 Hldgs %
16.49%
Holding
1,533
New
211
Increased
794
Reduced
387
Closed
126

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$52.4M
2
JNJ icon
Johnson & Johnson
JNJ
+$39.1M
3
TMUS icon
T-Mobile US
TMUS
+$37.2M
4
ABBV icon
AbbVie
ABBV
+$35.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$34.6M

Sector Composition

Rank Sector Weight
1 Technology 29.28%
2 Financials 10.77%
3 Consumer Discretionary 8.99%
4 Industrials 8.73%
5 Healthcare 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNXC icon
1051
Concentrix
CNXC
$1.45B
$363K 0.01%
5,734
+1,564
+38% +$93.9K
KRYS icon
1052
Krystal Biotech
KRYS
$9.92B
$361K 0.01%
1,965
+549
+39% +$92.2K
CRTO icon
1053
Criteo
CRTO
$1.05B
$361K 0.01%
9,562
+2,443
+34% +$89.4K
NBIX icon
1054
Neurocrine Biosciences
NBIX
$17.8B
$360K 0.01%
2,613
-95,141
-97% -$13M
WNS
1055
DELISTED
WNS Holdings
WNS
$360K 0.01%
+6,847
New +$339K
AMKR icon
1056
Amkor Technology
AMKR
$14.7B
$359K 0.01%
+8,979
New +$297K
SCHX icon
1057
Schwab US Large- Cap ETF
SCHX
$70.9B
$359K 0.01%
16,755
PLOW icon
1058
Douglas Dynamics
PLOW
$1.04B
$359K 0.01%
+15,321
New +$364K
AAL icon
1059
American Airlines Group
AAL
$9.66B
$355K 0.01%
31,305
-24,035
-43% -$316K
RUN icon
1060
Sunrun
RUN
$2.34B
$354K 0.01%
29,806
-8,407
-22% -$103K
VERX icon
1061
Vertex
VERX
$2.09B
$352K 0.01%
9,764
-2,749
-22% -$88.5K
CET
1062
Central Securities Corp
CET
$1.56B
$350K 0.01%
+7,956
New +$336K
SYF icon
1063
Synchrony
SYF
$24.3B
$350K 0.01%
+7,414
New +$322K
FMS icon
1064
Fresenius Medical Care
FMS
$13.4B
$349K 0.01%
+18,264
New +$372K
VCYT icon
1065
Veracyte
VCYT
$4.48B
$349K 0.01%
16,084
-768
-5% -$16.1K
U icon
1066
Unity
U
$12.9B
$348K 0.01%
21,424
-11,347
-35% -$243K
PPL
1067
PPL Corp
PPL
$27.3B
$347K 0.01%
12,537
+2,781
+29% +$78K
TAC icon
1068
TransAlta
TAC
$4.22B
$347K 0.01%
48,957
+28,643
+141% +$196K
RRX icon
1069
Regal Rexnord
RRX
$13.7B
$344K 0.01%
2,548
+791
+45% +$123K
ASR icon
1070
Grupo Aeroportuario del Sureste
ASR
$8.03B
$344K 0.01%
1,147
+308
+37% +$101K
GFS icon
1071
GlobalFoundries
GFS
$28B
$343K 0.01%
6,779
+741
+12% +$37.1K
TFIN icon
1072
Triumph Financial Inc
TFIN
$1.82B
$342K 0.01%
4,188
-7,359
-64% -$548K
ALB icon
1073
Albemarle
ALB
$13.5B
$342K 0.01%
3,581
-485
-12% -$57.7K
BALL icon
1074
Ball Corp
BALL
$17.3B
$340K 0.01%
5,662
+1,273
+29% +$85.3K
UMH
1075
UMH Properties
UMH
$1.33B
$340K 0.01%
21,249
-4,390
-17% -$68.3K

Similar funds

Vident Advisory's Q2 2024 Portfolio in Review

As of Q2 2024, Vident Advisory held 1,533 positions worth $3.62B, down 25% from $4.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Vident Advisory withdrew a net $1.18B in Q2 2024, closing 126 positions and reducing 387 holdings. Its most notable exit was Enterprise Products Partners, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Vident Advisory opened a new position in Vanguard Intermediate-Term Treasury ETF worth $19M.

  • Vident Advisory's largest Q2 2024 buy was Vanguard Intermediate-Term Treasury ETF: 326,646 shares worth $19M.
  • Vident Advisory added most to Tesla in Q2 2024, an estimated $29.1M increase.
  • Vident Advisory's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $52.4M.
  • Vident Advisory fully exited Enterprise Products Partners in Q2 2024, selling an estimated $20M.
  • Vident Advisory's ten largest holdings make up 16% of its $3.62B portfolio in Q2 2024.
  • Vident Advisory opened 211 new positions and closed 126 in Q2 2024.
  • Vident Advisory's portfolio value fell 25% quarter-over-quarter to $3.62B.

Based on Vident Advisory's 13F filing for Q2 2024, filed 14 Aug 2024.